ANDREAKOS, Evangelos, Laurent ABEL, Donald C VINH, Elzbieta KAJA, Beth A DROLET, Qian ZHANG, Cliona FARRELLY, Giuseppe NOVELLI, Carlos RODRIGUEZ-GALLEGO, Filomeen HAERYNCK, Carolina PRANDO, Aurora PUJOL, Helen C SU, Jean-Laurent CASANOVA, Andras N SPAAN, Paul BASTARD, Catherine M BIGGS, Benedetta BIGIO, Bertrand BOISSON, Alexandre BOLZE, Anastasiia BONDARENKO, Petter BRODIN, Samya CHAKRAVORTY, John CHRISTODOULOU, Aurelie COBAT, Antonio CONDINO-NETO, Stefan N CONSTANTINESCU, Hagit Baris FELDMAN, Jacques FELLAY, Rabih HALWANI, Emmanuelle JOUANGUY, Yu-Lung LAU, Isabelle MEYTS, Trine H MOGENSEN, Satoshi OKADA, Keisuke OKAMOTO, Tayfun OZCELIK, Qiang PAN-HAMMARSTROM, Anna M PLANAS, Anne PUEL, Lluis QUINTANA-MURCI, Laurent RENIA, Igor RESNICK, Anna SEDIVA, Anna SHCHERBINA, Ondřej SLABÝ, Ivan TANCEVSKI, Stuart E TURVEY, K M Furkan UDDIN, van de Beek DIEDERIK, Mayana ZATZ, Pawel ZAWADZKI and Shen-Ying ZHANG. A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection. Nature immunology. 2022, vol. 23, No 2, p. 159-164. ISSN 1529-2908. Available from: https://dx.doi.org/10.1038/s41590-021-01030-z.
Other formats:   BibTeX LaTeX RIS
Basic information
Original name A global effort to dissect the human genetic basis of resistance to SARS-CoV-2 infection
Authors ANDREAKOS, Evangelos, Laurent ABEL, Donald C VINH, Elzbieta KAJA, Beth A DROLET, Qian ZHANG, Cliona FARRELLY, Giuseppe NOVELLI, Carlos RODRIGUEZ-GALLEGO, Filomeen HAERYNCK, Carolina PRANDO, Aurora PUJOL, Helen C SU, Jean-Laurent CASANOVA, Andras N SPAAN, Paul BASTARD, Catherine M BIGGS, Benedetta BIGIO, Bertrand BOISSON, Alexandre BOLZE, Anastasiia BONDARENKO, Petter BRODIN, Samya CHAKRAVORTY, John CHRISTODOULOU, Aurelie COBAT, Antonio CONDINO-NETO, Stefan N CONSTANTINESCU, Hagit Baris FELDMAN, Jacques FELLAY, Rabih HALWANI, Emmanuelle JOUANGUY, Yu-Lung LAU, Isabelle MEYTS, Trine H MOGENSEN, Satoshi OKADA, Keisuke OKAMOTO, Tayfun OZCELIK, Qiang PAN-HAMMARSTROM, Anna M PLANAS, Anne PUEL, Lluis QUINTANA-MURCI, Laurent RENIA, Igor RESNICK, Anna SEDIVA, Anna SHCHERBINA, Ondřej SLABÝ (203 Czech Republic, guarantor, belonging to the institution), Ivan TANCEVSKI, Stuart E TURVEY, K M Furkan UDDIN, van de Beek DIEDERIK, Mayana ZATZ, Pawel ZAWADZKI and Shen-Ying ZHANG.
Edition Nature immunology, 2022, 1529-2908.
Other information
Original language English
Type of outcome Article in a journal
Field of Study 30102 Immunology
Country of publisher Germany
Confidentiality degree is not subject to a state or trade secret
WWW URL
Impact factor Impact factor: 30.500
RIV identification code RIV/00216224:14740/22:00128828
Organization unit Central European Institute of Technology
Doi http://dx.doi.org/10.1038/s41590-021-01030-z
UT WoS 000708815900001
Keywords in English Animals; COVID-19; Disease Resistance; Genetic Heterogeneity; Genetic Predisposition to Disease; Host-Pathogen Interactions; Humans; Phenotype; Protective Factors; Risk Assessment; Risk Factors; SARS-CoV-2
Tags 14110513, podil, rivok
Tags International impact, Reviewed
Changed by Changed by: Mgr. Pavla Foltynová, Ph.D., učo 106624. Changed: 8/3/2023 19:37.
Abstract
SARS-CoV-2 infections display tremendous interindividual variability, ranging from asymptomatic infections to life-threatening disease. Inborn errors of, and autoantibodies directed against, type I interferons (IFNs) account for about 20% of critical COVID-19 cases among SARS-CoV-2-infected individuals. By contrast, the genetic and immunological determinants of resistance to infection per se remain unknown. Following the discovery that autosomal recessive deficiency in the DARC chemokine receptor confers resistance to Plasmodium vivax, autosomal recessive deficiencies of chemokine receptor 5 (CCR5) and the enzyme FUT2 were shown to underlie resistance to HIV-1 and noroviruses, respectively. Along the same lines, we propose a strategy for identifying, recruiting, and genetically analyzing individuals who are naturally resistant to SARS-CoV-2 infection.
PrintDisplayed: 19/7/2024 18:27